Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 72 |
| List of Tables | 65 | 8 |
| List of Figures | 73 | 1 |
| Introduction | 74 | 1 |
| Global Markets Direct Report Coverage | 74 | 1 |
| Alzheimer's Disease Overview | 75 | 1 |
| Therapeutics Development | 76 | 2 |
| Pipeline Products for Alzheimer's Disease Overview | 76 | 1 |
| Pipeline Products for Alzheimer's Disease Comparative Analysis | 77 | 1 |
| Alzheimer's Disease Therapeutics under Development by Companies | 78 | 21 |
| Alzheimer's Disease Therapeutics under Investigation by Universities/Institutes | 99 | 7 |
| Alzheimer's Disease Pipeline Products Glance | 106 | 4 |
| Late Stage Products | 106 | 1 |
| Clinical Stage Products | 107 | 1 |
| Early Stage Products | 108 | 1 |
| Unknown Stage Products | 109 | 1 |
| Alzheimer's Disease Products under Development by Companies | 110 | 30 |
| Alzheimer's Disease Products under Investigation by Universities/Institutes | 140 | 10 |
| Alzheimer's Disease Companies Involved in Therapeutics Development | 150 | 228 |
| AB Science SA | 150 | 1 |
| AbbVie Inc | 151 | 1 |
| AC Immune SA | 152 | 1 |
| Accera, Inc. | 153 | 1 |
| Acelot, Inc. | 154 | 1 |
| Actinogen Limited | 155 | 1 |
| Acumen Pharmaceuticals, Inc. | 156 | 1 |
| Addex Therapeutics Ltd | 157 | 1 |
| Affibody AB | 158 | 1 |
| AFFiRiS AG | 159 | 1 |
| Alector LLC | 160 | 1 |
| Alkermes Plc | 161 | 1 |
| Allergan Plc | 162 | 1 |
| Allinky Biopharma | 163 | 1 |
| ALSP, Inc. | 164 | 1 |
| Alzhyme Pty Ltd | 165 | 1 |
| Alzinova AB | 166 | 1 |
| AlzProtect SAS | 167 | 1 |
| Amarantus Bioscience Holdings, Inc. | 168 | 1 |
| Amgen Inc. | 169 | 1 |
| Anavex Life Sciences Corp. | 170 | 1 |
| Aphios Corporation | 171 | 1 |
| Apodemus AB | 172 | 1 |
| Applied Research using OMIC Sciences, S.L. | 173 | 1 |
| Araclon Biotech, S.L. | 174 | 1 |
| Archer Pharmaceuticals, Inc. | 175 | 1 |
| ArmaGen Inc. | 176 | 1 |
| Artery Therapeutics, Inc. | 177 | 1 |
| AskAt Inc. | 178 | 1 |
| Astellas Pharma Inc. | 179 | 1 |
| AstraZeneca Plc | 180 | 1 |
| Asubio Pharma Co., Ltd. | 181 | 1 |
| Ausio Pharmaceuticals, LLC | 182 | 1 |
| Avineuro Pharmaceuticals, Inc. | 183 | 1 |
| Axon Neuroscience SE | 184 | 1 |
| Axovant Sciences Ltd. | 185 | 1 |
| Axsome Therapeutics, Inc. | 186 | 1 |
| Axxam SpA | 187 | 1 |
| Beactica AB | 188 | 1 |
| Berg LLC | 189 | 1 |
| BioArctic Neuroscience AB | 190 | 1 |
| Bioasis Technologies Inc. | 191 | 1 |
| Biogen Inc | 192 | 1 |
| Biomar Microbial Technologies | 193 | 1 |
| Bionature E.A. Ltd. | 194 | 1 |
| Boehringer Ingelheim GmbH | 195 | 1 |
| Bristol-Myers Squibb Company | 196 | 1 |
| Bsim2 | 197 | 1 |
| Cardax Pharmaceuticals, Inc. | 198 | 1 |
| Carna Biosciences, Inc. | 199 | 1 |
| Celon Pharma Sp. z o.o. | 200 | 1 |
| CHA Bio &Diostech Co., Ltd. | 201 | 1 |
| Chase Pharmaceuticals Corporation | 202 | 1 |
| Clera Inc. | 203 | 1 |
| Cognition Therapeutics, Inc. | 204 | 1 |
| Cognosci, Inc. | 205 | 1 |
| CohBar, Inc. | 206 | 1 |
| Connexios Life Sciences Pvt. Ltd. | 207 | 1 |
| ContraVir Pharmaceuticals, Inc. | 208 | 1 |
| Corium International, Inc. | 209 | 1 |
| Coronis Partners Ltd. | 210 | 1 |
| Cortice Biosciences, Inc. | 211 | 1 |
| Critical Outcome Technologies Inc. | 212 | 1 |
| Crossbeta Biosciences B.V. | 213 | 1 |
| D-Pharm Ltd. | 214 | 1 |
| Daewoong Pharmaceutical Co., Ltd. | 215 | 1 |
| Daiichi Sankyo Company, Limited | 216 | 1 |
| Daval International Limited | 217 | 1 |
| DermaXon, LLC | 218 | 1 |
| Dongkook Pharmaceutical Co., Ltd. | 219 | 1 |
| Eisai Co., Ltd. | 220 | 1 |
| Eli Lilly and Company | 221 | 1 |
| Emergent BioSolutions Inc. | 222 | 1 |
| EncephRx, Inc. | 223 | 1 |
| Endece, LLC | 224 | 1 |
| ENKAM Pharmaceuticals A/S | 225 | 1 |
| Ensemble Therapeutics Corporation | 226 | 1 |
| Ensol Biosciences Inc. | 227 | 1 |
| Epigen Biosciences, Inc. | 228 | 1 |
| Euroscreen S.A. | 229 | 1 |
| Evotec AG | 230 | 1 |
| F. Hoffmann-La Roche Ltd. | 231 | 1 |
| FORUM Pharmaceuticals Inc. | 232 | 1 |
| Genentech, Inc. | 233 | 1 |
| Genervon Biopharmaceuticals, LLC | 234 | 1 |
| GlaxoSmithKline Plc | 235 | 1 |
| GliaCure Inc. | 236 | 1 |
| Glialogix, Inc. | 237 | 1 |
| Golden Biotechnology Corp. | 238 | 1 |
| Grifols, S.A. | 239 | 1 |
| H. Lundbeck A/S | 240 | 1 |
| Heptares Therapeutics Limited | 241 | 1 |
| HitGen LTD | 242 | 1 |
| Humanetics Corporation | 243 | 1 |
| Ichor Medical Systems, Inc. | 244 | 1 |
| Icure Pharmaceutical Inc. | 245 | 1 |
| Immungenetics AG | 246 | 1 |
| Impel NeuroPharma, Inc. | 247 | 1 |
| ImStar Therapeutics Inc. | 248 | 1 |
| Inovio Pharmaceuticals, Inc. | 249 | 1 |
| IntelGenx Corp. | 250 | 1 |
| Intellect Neurosciences, Inc. | 251 | 1 |
| Intra-Cellular Therapies, Inc. | 252 | 1 |
| INVENT Pharmaceuticals, Inc. | 253 | 1 |
| Io Therapeutics, Inc. | 254 | 1 |
| Iproteos S.L. | 255 | 1 |
| Jeil Pharmaceutical Co., Ltd. | 256 | 1 |
| Jiangsu Kanion Pharmaceutical Co., Ltd. | 257 | 1 |
| Johnson &Johnson | 258 | 1 |
| K-Stemcell Co., Ltd. | 259 | 1 |
| Kadmon Corporation, LLC | 260 | 1 |
| Kalgene Pharmaceuticals Inc. | 261 | 1 |
| Kareus Therapeutics, SA | 262 | 1 |
| KineMed, Inc. | 263 | 1 |
| Krenitsky Pharmaceuticals Inc. | 264 | 1 |
| Kyowa Hakko Kirin Co., Ltd. | 265 | 1 |
| Lead Discovery Center GmbH | 266 | 1 |
| Les Laboratoires Servier SAS | 267 | 1 |
| Lipopharma Therapeutics SL | 268 | 1 |
| Living Cell Technologies Limited | 269 | 1 |
| Lupin Limited | 270 | 1 |
| M3 Biotechnology, Inc. | 271 | 1 |
| ManRos Therapeutics | 272 | 1 |
| MedDay SA | 273 | 1 |
| Medestea Research &Production S.p.A. | 274 | 1 |
| MedImmune, LLC | 275 | 1 |
| Medisyn Technologies, Inc. | 276 | 1 |
| MEDRx Co., Ltd. | 277 | 1 |
| Merck &Co., Inc. | 278 | 1 |
| Metabolic Solutions Development Company, LLC | 279 | 1 |
| Mithridion, Inc. | 280 | 1 |
| Mitochon Pharmaceuticals, Inc. | 281 | 1 |
| NAL Pharmaceuticals Ltd. | 282 | 1 |
| Nanomerics Ltd | 283 | 1 |
| Nanotherapeutics, Inc. | 284 | 1 |
| Neuralstem, Inc. | 285 | 1 |
| Neuraltus Pharmaceuticals, Inc. | 286 | 1 |
| Neurim Pharmaceuticals Ltd | 287 | 1 |
| Neuro-Sys SAS | 288 | 1 |
| Neurodyn Inc. | 289 | 1 |
| NeuroGeneration, Inc. | 290 | 1 |
| NeuroGenetic Pharmaceuticals, Inc. | 291 | 1 |
| NeuroNascent, Inc. | 292 | 1 |
| Neuronax SAS | 293 | 1 |
| NeurOp, Inc | 294 | 1 |
| NeuroPhage Pharmaceuticals, Inc. | 295 | 1 |
| Neuropore Therapies, Inc. | 296 | 1 |
| Neurotez, Inc. | 297 | 1 |
| New World Laboratories, Inc. | 298 | 1 |
| nLife Therapeutics, S.L. | 299 | 1 |
| NLS Pharma Group | 300 | 1 |
| Novartis AG | 301 | 1 |
| NsGene A/S | 302 | 1 |
| Oligomerix, inc. | 303 | 1 |
| ORPHIT | 304 | 1 |
| Oryzon Genomics SA | 305 | 1 |
| Otsuka Holdings Co., Ltd. | 306 | 1 |
| P2D Bioscience | 307 | 1 |
| Pain Therapeutics, Inc. | 308 | 1 |
| Palumed S.A. | 309 | 1 |
| Panacea Pharmaceuticals, Inc. | 310 | 1 |
| PeptiDream Inc. | 311 | 1 |
| Peptron, Inc. | 312 | 1 |
| Pfizer Inc. | 313 | 1 |
| PharmaKure Limited | 314 | 1 |
| PharmatrophiX, Inc. | 315 | 1 |
| Pharmaxis Limited | 316 | 1 |
| Pharnext SA | 317 | 1 |
| Phenomenome Discoveries, Inc. | 318 | 1 |
| Pivot Pharmaceuticals Inc | 319 | 1 |
| Prevacus, Inc. | 320 | 1 |
| Probiodrug AG | 321 | 1 |
| Progenra, Inc. | 322 | 1 |
| ProMIS Neurosciences Inc. | 323 | 1 |
| ProQR Therapeutics N.V. | 324 | 1 |
| Proteome Sciences Plc | 325 | 1 |
| Proteostasis Therapeutics, Inc. | 326 | 1 |
| QR Pharma, Inc. | 327 | 1 |
| Radius Health, Inc. | 328 | 1 |
| Regenera Pharma Ltd. | 329 | 1 |
| reMYND NV | 330 | 1 |
| Resverlogix Corp. | 331 | 1 |
| Retrotope, Inc | 332 | 1 |
| ReXceptor Inc. | 333 | 1 |
| Rodos BioTarget GmbH | 334 | 1 |
| Sage Therapeutics, Inc. | 335 | 1 |
| SanBio, Inc. | 336 | 1 |
| Saneron CCEL Therapeutics, Inc. | 337 | 1 |
| Saniona AB | 338 | 1 |
| Sanofi | 339 | 1 |
| Selvita S.A. | 340 | 1 |
| SeneXta Therapeutics SA | 341 | 1 |
| Serometrix, LLC | 342 | 1 |
| SignPath Pharma Inc | 343 | 1 |
| Signum Biosciences, Inc. | 344 | 1 |
| Simcere Pharmaceutical Group | 345 | 1 |
| SK Biopharmaceuticals Co., Ltd. | 346 | 1 |
| SOM Innovation Biotech SL | 347 | 1 |
| Spectrum Pharmaceuticals, Inc. | 348 | 1 |
| Stemedica Cell Technologies, Inc. | 349 | 1 |
| Sumitomo Dainippon Pharma Co., Ltd. | 350 | 1 |
| Summit Therapeutics Plc | 351 | 1 |
| Suven Life Sciences Ltd. | 352 | 1 |
| T3D Therapeutics, Inc. | 353 | 1 |
| Takeda Pharmaceutical Company Limited | 354 | 1 |
| TauRx Therapeutics Ltd. | 355 | 1 |
| TechnologieAllianz e. V. | 356 | 1 |
| TechnoPhage SA | 357 | 1 |
| Teijin Pharma Limited | 358 | 1 |
| Teikoku Pharma USA, Inc. | 359 | 1 |
| Tetra Discovery Partners LLC | 360 | 1 |
| Thera Neuropharma Inc | 361 | 1 |
| Therapix Biosciences Ltd | 362 | 1 |
| Tiziana Life Sciences Plc | 363 | 1 |
| Toyama Chemical Co., Ltd. | 364 | 1 |
| Transition Therapeutics Inc. | 365 | 1 |
| Treventis Corporation | 366 | 1 |
| TyrNovo Ltd. | 367 | 1 |
| UCB S.A. | 368 | 1 |
| Varinel, Inc. | 369 | 1 |
| Vaxine Pty Ltd | 370 | 1 |
| Virobay Inc. | 371 | 1 |
| Vitae Pharmaceuticals, Inc. | 372 | 1 |
| Voyager Therapeutics, Inc. | 373 | 1 |
| vTv Therapeutics Inc | 374 | 1 |
| Vybion, Inc. | 375 | 1 |
| Wellstat Therapeutics Corporation | 376 | 1 |
| Zhejiang Hisun Pharmaceutical Co., Ltd. | 377 | 1 |
| Alzheimer's Disease Therapeutics Assessment | 378 | 56 |
| Assessment by Monotherapy Products | 378 | 1 |
| Assessment by Combination Products | 379 | 1 |